左心室肌肉面积与放射衰减是否与接受化疗的晚期胰腺癌患者总生存期相关
本研究纳入98例接受化疗的晚期胰腺癌患者,于化疗前行动脉期CT测量左心室肌肉面积(LVMA)和左心室肌肉放射衰减(LVMRA),分析其与治疗反应及生存的关系。结果显示低LVMRA、低LVMA及多发转移与较短中位总生存期显著相关,LVMRA可能预测无进展生存期和总生存期。
要点
- 化疗前动脉期CT测量的低左心室肌肉放射衰减与较短中位总生存期显著相关。
- 低左心室肌肉面积及多发转移亦与较短中位总生存期显著相关。
- 部分缓解组的平均左心室肌肉放射衰减最高。
核心结论
- 左心室肌肉放射衰减可能较好地预测接受化疗的晚期胰腺癌患者的总生存期和无进展生存期。
研究设计与样本
- 研究纳入2009年至2018年间接受化疗前CT检查的98例化疗治疗的晚期胰腺癌患者。
- 采用化疗前动脉期CT测量左心室肌肉面积和左心室肌肉放射衰减。
- 采用Kaplan-Meier曲线分析总生存期和无进展生存期,并行单因素和多因素Cox回归分析。
诊断标准与关键数值
- 低LVMRA组中位OS为8.8个月 vs 高LVMRA组14个月(p=0.017)。
- 低LVMA组中位OS为12.2个月 vs 高LVMA组18.1个月(p=0.038)。
- 多发转移组中位OS为7.3个月 vs 无多发转移组13.5个月(p<0.001)。
- 低LVMRA组中位PFS为4.9个月 vs 高LVMRA组8.3个月(p=0.032)。
- 远处转移组中位PFS为5.4个月 vs 无远处转移组9.9个月(p=0.002)。
临床应用与阅片要点
- 部分缓解组的平均LVMRA最高(p=0.028),提示LVMRA可能与治疗反应相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate whether cardiac muscle area and radiation attenuation, determined using pre-chemotherapy computed tomography (CT), are associated with therapeutic response and overall survival (OS) in chemotherapy-treated advanced pancreatic cancer (APC) patients.
MATERIALS AND METHODS: Ninety-eight chemotherapy-treated APC patients who underwent pre-chemotherapy CT between 2009 and 2018 were considered. Left ventricular muscle area (LVMA) and left ventricular muscle radiation attenuation (LVMRA) were measured using pre-chemotherapy arterial-phase CT. OS and progression-free survival (PFS) were analysed using Kaplan-Meier curves. Univariate and multivariate Cox regression analyses were performed to analyse potential factors affecting OS and PFS.
RESULTS: Patients with low LVMRA, low LVMA at baseline CT, and multiple metastases had a significantly shorter median OS than patients with high LVMRA, high LVMA, and without multiple metastases (8.8 versus 14 months, p=0.017; 12.2 versus 18.1 months, p=0.038; 7.3 versus 13.5 months, p<0.001, respectively). Patients with low LVMRA and distant metastasis had a shorter median PFS than patients with high LVMRA and those without distant metastasis (4.9 versus 8.3 months, p=0.032; 5.4 versus 9.9 months, p=0.002, respectively). Moreover, the mean LVMRA was the highest in the partial response group (p=0.028).
CONCLUSION: LVMRA could well predict PFS and OS in chemotherapy-treated APC patients.
引用
- Cai Q, Mao Y, Yang Q, et al. Are left ventricular muscle area and radiation attenuation associated with overall survival in advanced pancreatic cancer patients treated with chemotherapy? Clin Radiol. 2019. PMID: 31858988. doi:10.1016/j.crad.2019.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。